Patrick Lamy - Net Worth and Insider Trading

Patrick Lamy Net Worth

The estimated net worth of Patrick Lamy is at least $601,038 dollars as of 2024-11-13. Patrick Lamy is the Senior VP, Commercial Strategy of Akero Therapeutics Inc and owns about 18,562 shares of Akero Therapeutics Inc (AKRO) stock worth over $601,038. Details can be seen in Patrick Lamy's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patrick Lamy has not made any transactions after 2024-06-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Patrick Lamy

To

Patrick Lamy Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Patrick Lamy owns 1 companies in total, including Akero Therapeutics Inc (AKRO) .

Click here to see the complete history of Patrick Lamy’s form 4 insider trades.

Insider Ownership Summary of Patrick Lamy

Ticker Comapny Transaction Date Type of Owner
AKRO Akero Therapeutics Inc 2024-06-11 See Remarks

Patrick Lamy Latest Holdings Summary

Patrick Lamy currently owns a total of 1 stock. Patrick Lamy owns 18,562 shares of Akero Therapeutics Inc (AKRO) as of June 11, 2024, with a value of $601,038.

Latest Holdings of Patrick Lamy

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AKRO Akero Therapeutics Inc 2024-06-11 18,562 32.38 601,038

Holding Weightings of Patrick Lamy


Patrick Lamy Form 4 Trading Tracker

According to the SEC Form 4 filings, Patrick Lamy has made a total of 1 transactions in Akero Therapeutics Inc (AKRO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Akero Therapeutics Inc is the sale of 569 shares on June 11, 2024, which brought Patrick Lamy around $12,882.

Insider Trading History of Patrick Lamy

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Patrick Lamy Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Patrick Lamy Ownership Network

Ownership Network List of Patrick Lamy

No Data

Ownership Network Relation of Patrick Lamy

Insider Network Chart

Patrick Lamy Owned Company Details

What does Akero Therapeutics Inc do?

Who are the key executives at Akero Therapeutics Inc?

Patrick Lamy is the See Remarks of Akero Therapeutics Inc. Other key executives at Akero Therapeutics Inc include Chief Development Officer Catriona Yale , director & President & CEO Andrew Cheng , and Chief Operating Officer Jonathan Young .

Akero Therapeutics Inc (AKRO) Insider Trades Summary

Over the past 18 months, Patrick Lamy made 1 insider transaction in Akero Therapeutics Inc (AKRO) with a net sale of 569. Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 171,998 shares made by Jonathan Young , a net sale of 150,584 shares made by Catriona Yale , and a net sale of 443,502 shares made by Andrew Cheng .

In summary, during the past 3 months, insiders sold 488,023 shares of Akero Therapeutics Inc (AKRO) in total and bought 0 shares, with a net sale of 488,023 shares. During the past 18 months, 1,237,763 shares of Akero Therapeutics Inc (AKRO) were sold and 1,320,000 shares were bought by its insiders, resulting in a net purchase of 82,237 shares.

Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Akero Therapeutics Inc Insider Transactions

No Available Data

Patrick Lamy Mailing Address

Above is the net worth, insider trading, and ownership report for Patrick Lamy. You might contact Patrick Lamy via mailing address: Akero Therapeutics, Inc., 601 Gateway Boulevard, Suite 350, South San Francisco Ca 94080.